BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17575216)

  • 21. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
    Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
    Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Responsiveness to recombinant human erythropoietin (rh-Epo) of marrow erythroid progenitors (CFU-E and BFU-E) from B-chronic lymphocytic leukemia (B-CLL).
    Tsatalas C; Chalkia P; Tsantali C; Kakoulidis I; Garyfallos A; Klonizakis I; Panayiotopoulos S
    J Exp Clin Cancer Res; 1997 Jun; 16(2):163-70. PubMed ID: 9261742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-erythroid activities of erythropoietin: Functional effects on murine dendritic cells.
    Lifshitz L; Prutchi-Sagiv S; Avneon M; Gassmann M; Mittelman M; Neumann D
    Mol Immunol; 2009 Feb; 46(4):713-21. PubMed ID: 19027957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD45 expression in low-grade B-cell non-Hodgkin's lymphomas.
    Carulli G; Cannizzo E; Zucca A; Buda G; Orciuolo E; Marini A; Petrini M
    Leuk Res; 2008 Feb; 32(2):263-7. PubMed ID: 17692374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of erythropoietin and its receptor in neuroblastomas.
    Sartelet H; Fabre M; Castaing M; Bosq J; Racu I; Lagonotte E; Scott V; Lecluse Y; Barette S; Michiels S; Vassal G
    Cancer; 2007 Sep; 110(5):1096-106. PubMed ID: 17647284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-secretion neutralization of transgene-derived effect: soluble erythropoietin receptor/IgG1Fc expressed in liver neutralizes erythropoietin produced in muscle.
    Maruyama H; Higuchi M; Higuchi N; Kameda S; Saito M; Sugawa M; Matsuzaki J; Neichi T; Yokoyama S; Miyazaki Y; Miyazaki J; Gejyo F
    J Gene Med; 2004 Feb; 6(2):228-37. PubMed ID: 14978776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythropoietin-dependent suppression of the expression of the beta subunits of the interleukin-3 receptor during erythroid differentiation.
    Carta C; Campisi S; Migliaccio G; Migliaccio AR
    Blood Cells Mol Dis; 2000 Oct; 26(5):467-78. PubMed ID: 11112384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneous intracellular expression of B-cell receptor components in B-cell chronic lymphocytic leukaemia (B-CLL) cells and effects of CD79b gene transfer on surface immunoglobulin levels in a B-CLL-derived cell line.
    Minuzzo S; Indraccolo S; Tosello V; Piovan E; Cabrelle A; Trentin L; Semenzato G; Amadori A
    Br J Haematol; 2005 Sep; 130(6):878-89. PubMed ID: 16156858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythropoietin and erythropoietin receptor coexpression is associated with poor survival in stage I non-small cell lung cancer.
    Saintigny P; Besse B; Callard P; Vergnaud AC; Czernichow S; Colombat M; Girard P; Validire P; Breau JL; Bernaudin JF; Soria JC
    Clin Cancer Res; 2007 Aug; 13(16):4825-31. PubMed ID: 17699861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection and quantification of functionally defined hematopoietic progenitor cells and tissue specific mRNA within the peripheral blood of myeloma patients after administration of granulocyte colony-stimulating factor and erythropoietin.
    Grassinger J; Mueller G; Hart C; Nilsson SK; Haylock DN; Andreesen R; Hennemann B
    Eur J Haematol; 2008 Jan; 80(1):20-30. PubMed ID: 18028434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autocrine function of erythropoietin in IGF-1-induced erythropoietin biosynthesis.
    Kim I; Kim CH; Yim YS; Ahn YS
    Neuroreport; 2008 Nov; 19(17):1699-703. PubMed ID: 18841090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autocrine stimulation by erythropoietin and autonomous growth of human erythroid leukemic cells in vitro.
    Mitjavila MT; Le Couedic JP; Casadevall N; Navarro S; Villeval JL; Dubart A; Vainchenker W
    J Clin Invest; 1991 Sep; 88(3):789-97. PubMed ID: 1653276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of CD66 in non-Hodgkin lymphomas and multiple myeloma.
    Josef K; Heidi M; Robert P; Pavel K; Marek T
    Eur J Haematol; 2010 Dec; 85(6):496-501. PubMed ID: 20887387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertension induced by erythropoietin has a correlation with truncated erythropoietin receptor mRNA in endothelial progenitor cells of hemodialysis patients.
    Ioka T; Tsuruoka S; Ito C; Iwaguro H; Asahara T; Fujimura A; Kusano E
    Clin Pharmacol Ther; 2009 Aug; 86(2):154-9. PubMed ID: 19458615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Density expression of the CD20 antigen on population of tumor cells in patients with chronic B-lymphocyte lymphoproliferative diseases].
    Suková V; Klabusay M; Coupek P; Brychtová Y; Doubek M; Mayer J
    Cas Lek Cesk; 2006; 145(9):712-6; discussion 716-7. PubMed ID: 17091727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of erythropoietin gene expression and its use in medicine.
    Jelkmann W
    Methods Enzymol; 2007; 435():179-97. PubMed ID: 17998055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells.
    Um M; Gross AW; Lodish HF
    Cell Signal; 2007 Mar; 19(3):634-45. PubMed ID: 17045782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disease-related anemia in chronic lymphocytic leukemia is not due to intrinsic defects of erythroid precursors: a possible pathogenetic role for tumor necrosis factor-alpha.
    Tsopra OA; Ziros PG; Lagadinou ED; Symeonidis A; Kouraklis-Symeonidis A; Thanopoulou E; Angelopoulou MK; Vassilakopoulos TP; Pangalis GA; Zoumbos NC
    Acta Haematol; 2009; 121(4):187-95. PubMed ID: 19468203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of human eosinophils by IL-13. Induction of CD69 surface antigen, its relationship to messenger RNA expression, and promotion of cellular viability.
    Luttmann W; Knoechel B; Foerster M; Matthys H; Virchow JC; Kroegel C
    J Immunol; 1996 Aug; 157(4):1678-83. PubMed ID: 8759755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of BAFF-R and TACI in reactive lymphoid tissues and B-cell lymphomas.
    Wada K; Maeda K; Tajima K; Kato T; Kobata T; Yamakawa M
    Histopathology; 2009 Jan; 54(2):221-32. PubMed ID: 19207947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.